
Joseph Moore Pelham
Examiner (ID: 12389, Phone: (571)272-4786 , Office: P/3742 )
| Most Active Art Unit | 3742 |
| Art Unit(s) | 3761, 2106, 3742 |
| Total Applications | 2549 |
| Issued Applications | 1998 |
| Pending Applications | 99 |
| Abandoned Applications | 463 |
Applications
| Application number | Title of the application | Filing Date | Status |
|---|---|---|---|
Array
(
[id] => 10499611
[patent_doc_number] => 09228007
[patent_country] => US
[patent_kind] => B1
[patent_issue_date] => 2016-01-05
[patent_title] => 'Recombinant human progenitor cells, engineered human thymocytes, and engineered human T cells'
[patent_app_type] => utility
[patent_app_number] => 13/045073
[patent_app_country] => US
[patent_app_date] => 2011-03-10
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 16
[patent_figures_cnt] => 20
[patent_no_of_words] => 11541
[patent_no_of_claims] => 12
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 210
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13045073
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/045073 | Recombinant human progenitor cells, engineered human thymocytes, and engineered human T cells | Mar 9, 2011 | Issued |
Array
(
[id] => 5958496
[patent_doc_number] => 20110182883
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2011-07-28
[patent_title] => 'NOVEL GENE DISRUPTIONS, COMPOSITIONS AND METHODS RELATING THERETO'
[patent_app_type] => utility
[patent_app_number] => 13/040049
[patent_app_country] => US
[patent_app_date] => 2011-03-03
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 102
[patent_figures_cnt] => 102
[patent_no_of_words] => 209639
[patent_no_of_claims] => 20
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0182/20110182883.pdf
[firstpage_image] =>[orig_patent_app_number] => 13040049
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/040049 | NOVEL GENE DISRUPTIONS, COMPOSITIONS AND METHODS RELATING THERETO | Mar 2, 2011 | Abandoned |
Array
(
[id] => 7487238
[patent_doc_number] => 20110251077
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2011-10-13
[patent_title] => 'Methods and Systems for Diagnosis of Non-Central Nervous System (CNS) Diseases in CNS Samples'
[patent_app_type] => utility
[patent_app_number] => 13/036536
[patent_app_country] => US
[patent_app_date] => 2011-02-28
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 203
[patent_figures_cnt] => 203
[patent_no_of_words] => 32567
[patent_no_of_claims] => 21
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13036536
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/036536 | Methods and Systems for Diagnosis of Non-Central Nervous System (CNS) Diseases in CNS Samples | Feb 27, 2011 | Abandoned |
Array
(
[id] => 8670999
[patent_doc_number] => 20130045537
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2013-02-21
[patent_title] => 'METHODS AND COMPOSITIONS RELATING TO MULTICILIATE CELL DIFFERENTIATION'
[patent_app_type] => utility
[patent_app_number] => 13/580645
[patent_app_country] => US
[patent_app_date] => 2011-02-23
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 15
[patent_figures_cnt] => 15
[patent_no_of_words] => 15183
[patent_no_of_claims] => 29
[patent_no_of_ind_claims] => 7
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13580645
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/580645 | METHODS AND COMPOSITIONS RELATING TO MULTICILIATE CELL DIFFERENTIATION | Feb 22, 2011 | Abandoned |
Array
(
[id] => 6101705
[patent_doc_number] => 20110165197
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2011-07-07
[patent_title] => 'ADJUVANT COMPOSITIONS AND METHODS FOR ENHANCING IMMUNE RESPONSES TO POLYNUCLEOTIDE-BASED VACCINES'
[patent_app_type] => utility
[patent_app_number] => 13/031064
[patent_app_country] => US
[patent_app_date] => 2011-02-18
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 13
[patent_figures_cnt] => 13
[patent_no_of_words] => 15883
[patent_no_of_claims] => 18
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0165/20110165197.pdf
[firstpage_image] =>[orig_patent_app_number] => 13031064
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/031064 | Adjuvant compositions and methods for enhancing immune responses to polynucleotide-based vaccines | Feb 17, 2011 | Issued |
Array
(
[id] => 6079953
[patent_doc_number] => 20110142807
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2011-06-16
[patent_title] => 'Mesenchymal Stem Cells and Uses Therefor'
[patent_app_type] => utility
[patent_app_number] => 12/974125
[patent_app_country] => US
[patent_app_date] => 2010-12-21
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 9
[patent_figures_cnt] => 9
[patent_no_of_words] => 9236
[patent_no_of_claims] => 26
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0142/20110142807.pdf
[firstpage_image] =>[orig_patent_app_number] => 12974125
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/974125 | Mesenchymal Stem Cells and Uses Therefor | Dec 20, 2010 | Abandoned |
Array
(
[id] => 6176102
[patent_doc_number] => 20110177590
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2011-07-21
[patent_title] => 'Bioprinted Nanoparticles and Methods of Use'
[patent_app_type] => utility
[patent_app_number] => 12/966645
[patent_app_country] => US
[patent_app_date] => 2010-12-13
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 31
[patent_figures_cnt] => 31
[patent_no_of_words] => 16472
[patent_no_of_claims] => 27
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0177/20110177590.pdf
[firstpage_image] =>[orig_patent_app_number] => 12966645
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/966645 | Bioprinted Nanoparticles and Methods of Use | Dec 12, 2010 | Abandoned |
Array
(
[id] => 6159397
[patent_doc_number] => 20110158959
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2011-06-30
[patent_title] => 'IMMUNOPHENOTYPE AND IMMUNOGENICITY OF HUMAN ADIPOSE DERIVED CELLS'
[patent_app_type] => utility
[patent_app_number] => 12/955639
[patent_app_country] => US
[patent_app_date] => 2010-11-29
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 6
[patent_figures_cnt] => 6
[patent_no_of_words] => 22180
[patent_no_of_claims] => 25
[patent_no_of_ind_claims] => 11
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0158/20110158959.pdf
[firstpage_image] =>[orig_patent_app_number] => 12955639
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/955639 | IMMUNOPHENOTYPE AND IMMUNOGENICITY OF HUMAN ADIPOSE DERIVED CELLS | Nov 28, 2010 | Abandoned |
Array
(
[id] => 10051038
[patent_doc_number] => 09090907
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2015-07-28
[patent_title] => 'Modified INSM1-promoter for neuroendocrine tumor therapy and diagnostics'
[patent_app_type] => utility
[patent_app_number] => 13/505823
[patent_app_country] => US
[patent_app_date] => 2010-11-08
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 12
[patent_figures_cnt] => 17
[patent_no_of_words] => 12004
[patent_no_of_claims] => 12
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 237
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13505823
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/505823 | Modified INSM1-promoter for neuroendocrine tumor therapy and diagnostics | Nov 7, 2010 | Issued |
Array
(
[id] => 11749320
[patent_doc_number] => 09707318
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2017-07-18
[patent_title] => 'Compositions of novel bone patch in bone and vascular regeneration'
[patent_app_type] => utility
[patent_app_number] => 12/912853
[patent_app_country] => US
[patent_app_date] => 2010-10-27
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 1
[patent_figures_cnt] => 2
[patent_no_of_words] => 5517
[patent_no_of_claims] => 7
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 95
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 12912853
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/912853 | Compositions of novel bone patch in bone and vascular regeneration | Oct 26, 2010 | Issued |
Array
(
[id] => 6202395
[patent_doc_number] => 20110065181
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2011-03-17
[patent_title] => 'Methods and Apparatus for Segregation of Particles'
[patent_app_type] => utility
[patent_app_number] => 12/910299
[patent_app_country] => US
[patent_app_date] => 2010-10-22
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 14
[patent_figures_cnt] => 14
[patent_no_of_words] => 27604
[patent_no_of_claims] => 30
[patent_no_of_ind_claims] => 13
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0065/20110065181.pdf
[firstpage_image] =>[orig_patent_app_number] => 12910299
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/910299 | Methods and Apparatus for Segregation of Particles | Oct 21, 2010 | Abandoned |
Array
(
[id] => 6195484
[patent_doc_number] => 20110027238
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2011-02-03
[patent_title] => 'Mesenchymal Stem Cells and Uses Therefor'
[patent_app_type] => utility
[patent_app_number] => 12/908119
[patent_app_country] => US
[patent_app_date] => 2010-10-20
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 9
[patent_figures_cnt] => 9
[patent_no_of_words] => 9843
[patent_no_of_claims] => 13
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0027/20110027238.pdf
[firstpage_image] =>[orig_patent_app_number] => 12908119
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/908119 | Mesenchymal Stem Cells and Uses Therefor | Oct 19, 2010 | Abandoned |
Array
(
[id] => 6125700
[patent_doc_number] => 20110086100
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2011-04-14
[patent_title] => 'Polyethylene Glycol Aerogels for Targeted Delivery of Pharmaceutical Drubs'
[patent_app_type] => utility
[patent_app_number] => 12/902184
[patent_app_country] => US
[patent_app_date] => 2010-10-12
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 6443
[patent_no_of_claims] => 19
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0086/20110086100.pdf
[firstpage_image] =>[orig_patent_app_number] => 12902184
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/902184 | Polyethylene glycol aerogels for targeted delivery of pharmaceutical drubs | Oct 11, 2010 | Issued |
Array
(
[id] => 8393609
[patent_doc_number] => 20120231450
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2012-09-13
[patent_title] => 'NOVEL PACEMAKER CELL'
[patent_app_type] => utility
[patent_app_number] => 13/499379
[patent_app_country] => US
[patent_app_date] => 2010-09-29
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 19
[patent_figures_cnt] => 19
[patent_no_of_words] => 11649
[patent_no_of_claims] => 20
[patent_no_of_ind_claims] => 5
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13499379
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/499379 | NOVEL PACEMAKER CELL | Sep 28, 2010 | Abandoned |
Array
(
[id] => 7807233
[patent_doc_number] => 20120058187
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2012-03-08
[patent_title] => 'WATER-IN-OIL TYPE EMULSION FOR TREATING A DISEASE OF THE EYE'
[patent_app_type] => utility
[patent_app_number] => 12/875805
[patent_app_country] => US
[patent_app_date] => 2010-09-03
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 3562
[patent_no_of_claims] => 20
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0058/20120058187.pdf
[firstpage_image] =>[orig_patent_app_number] => 12875805
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/875805 | WATER-IN-OIL TYPE EMULSION FOR TREATING A DISEASE OF THE EYE | Sep 2, 2010 | Abandoned |
Array
(
[id] => 8416730
[patent_doc_number] => 20120244230
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2012-09-27
[patent_title] => 'POLYVALENT POLYNUCLEOTIDE NANOPARTICLE CONJUGATES AS DELIVERY VEHICLES FOR A CHEMOTHERAPEUTIC AGENT'
[patent_app_type] => utility
[patent_app_number] => 13/393454
[patent_app_country] => US
[patent_app_date] => 2010-09-01
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 4
[patent_figures_cnt] => 4
[patent_no_of_words] => 19422
[patent_no_of_claims] => 26
[patent_no_of_ind_claims] => 7
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13393454
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/393454 | POLYVALENT POLYNUCLEOTIDE NANOPARTICLE CONJUGATES AS DELIVERY VEHICLES FOR A CHEMOTHERAPEUTIC AGENT | Aug 31, 2010 | Abandoned |
Array
(
[id] => 6174539
[patent_doc_number] => 20110177130
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2011-07-21
[patent_title] => 'METHODS FOR PREPARATION OF LIPID-ENCAPSULATED THERAPEUTIC AGENTS'
[patent_app_type] => utility
[patent_app_number] => 12/871537
[patent_app_country] => US
[patent_app_date] => 2010-08-30
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 6
[patent_figures_cnt] => 6
[patent_no_of_words] => 15455
[patent_no_of_claims] => 12
[patent_no_of_ind_claims] => 8
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0177/20110177130.pdf
[firstpage_image] =>[orig_patent_app_number] => 12871537
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/871537 | METHODS FOR PREPARATION OF LIPID-ENCAPSULATED THERAPEUTIC AGENTS | Aug 29, 2010 | Abandoned |
Array
(
[id] => 10149266
[patent_doc_number] => 09181545
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2015-11-10
[patent_title] => 'Lipid encapsulating interfering RNA'
[patent_app_type] => utility
[patent_app_number] => 12/852379
[patent_app_country] => US
[patent_app_date] => 2010-08-06
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 32
[patent_figures_cnt] => 34
[patent_no_of_words] => 28345
[patent_no_of_claims] => 7
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 40
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 12852379
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/852379 | Lipid encapsulating interfering RNA | Aug 5, 2010 | Issued |
Array
(
[id] => 10077530
[patent_doc_number] => 09115374
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2015-08-25
[patent_title] => 'SYN3 compositions and methods'
[patent_app_type] => utility
[patent_app_number] => 12/838795
[patent_app_country] => US
[patent_app_date] => 2010-07-19
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 2
[patent_figures_cnt] => 2
[patent_no_of_words] => 9731
[patent_no_of_claims] => 7
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 128
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 12838795
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/838795 | SYN3 compositions and methods | Jul 18, 2010 | Issued |
Array
(
[id] => 6024940
[patent_doc_number] => 20110053266
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2011-03-03
[patent_title] => 'Methods, kits, and compositions for stem cell self-renewal'
[patent_app_type] => utility
[patent_app_number] => 12/802913
[patent_app_country] => US
[patent_app_date] => 2010-06-16
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 67
[patent_figures_cnt] => 67
[patent_no_of_words] => 33937
[patent_no_of_claims] => 27
[patent_no_of_ind_claims] => 4
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0053/20110053266.pdf
[firstpage_image] =>[orig_patent_app_number] => 12802913
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/802913 | Methods, kits, and compositions for stem cell self-renewal | Jun 15, 2010 | Abandoned |